News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Hidehito Horinouchi: ASCO Breakthrough 2024 is in 2 days
Photo taken from Hidehito Horinouchi/X
Aug 6, 2024, 11:58

Hidehito Horinouchi: ASCO Breakthrough 2024 is in 2 days

Hidehito Horinouchi, Oncologist at the Department of Thoracic Oncology at the National Cancer Center Hospital, recently shared a post on X:

“ASCO Breakthrough ASCOBT24 is in 2 days.

Date: August 8-10, 2024.

Program chair: Melvin LK Chua.

Reasons to Join:

  • Japan, Yokohama.
  • AI applications.
  • Precision oncology.
  • Robotics.
  • Novel Immunotherapy.”

Hidehito Horinouchi

Additional information.
Source: Hidehito Horinouchi/X

ASCO ASCOBT24 cancer Hidehito Horinouchi Melvin LK Chua National Cancer Center Hospital Novel Immunotherapy OncoDaily Oncology Precision Oncology
Special Coverage
Drugs
Dec 21, 2024, 10:38
Hanna Foster: Market cap and Revenue of Cancer NGS Drugs providers in 2024
Insight
Dec 21, 2024, 10:35
30 Years of Leadership in Immuno-Oncology - Agenus
Blog
Dec 21, 2024, 10:19
A Portrait of Germline Pathogenic Variants in Breast Cancer Genes in Brazil
Dialogues
Dec 21, 2024, 10:09
Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market
Blog
Dec 21, 2024, 09:22
When the world of science and sports comes together! - The V Foundation
Blog
Dec 21, 2024, 09:16
Timely cancer treatment isn’t just a goal, It’s a necessity - European Cancer Organisation
Science
Dec 21, 2024, 09:06
Toni Choueiri: The Final Analysis of the JAVELIN Renal 101 trial
Blog
Dec 21, 2024, 09:00
Miriam Mutebi: Does Nipple and Areola Size Matter?
Science
Dec 21, 2024, 08:51
Wafik S. El-Deiry: Our recent review on Targeting the SMURF2-HIF1α axis
Science
Dec 21, 2024, 08:48
Oncology Brothers: Another ALK inhibitor gets FDA approval
Science
Dec 21, 2024, 08:42
Eric K. Singhi: Decoding clinical trial jargon
Science
Dec 21, 2024, 08:37
Gustavo Viani: The Role of Radiotherapy on the management of HCC